| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1368-7646(98)80005-8 |
| P698 | PubMed publication ID | 16904407 |
| P2093 | author name string | T C Hamilton | |
| S W Johnson | |||
| K V Ferry | |||
| P2860 | cites work | Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 | Q24324482 |
| Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes | Q24644162 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast | Q27932242 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer | Q33489855 | ||
| A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support | Q69496423 | ||
| The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin | Q71533749 | ||
| Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents | Q71567325 | ||
| Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group | Q71676675 | ||
| Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells | Q71840966 | ||
| Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs | Q72459448 | ||
| Increased expression of cyclin B1 mRNA coincides with diminished G2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine | Q72836829 | ||
| In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells | Q73007151 | ||
| Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes | Q73030686 | ||
| Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer | Q73083003 | ||
| Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines | Q73177853 | ||
| Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras | Q73398527 | ||
| DNA interactions of bifunctional dinuclear platinum(II) antitumor agents | Q73480144 | ||
| Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance | Q73833646 | ||
| Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation | Q93607580 | ||
| A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer | Q33489936 | ||
| A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer | Q33496416 | ||
| Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy | Q34229177 | ||
| Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha | Q35606961 | ||
| The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines | Q35993429 | ||
| Enhancement of drug sensitivity of human malignancies by epidermal growth factor | Q36081127 | ||
| In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473 | Q36295090 | ||
| An in vitro study comparing the cytotoxicity of three platinum complexes with regard to the effect of thiol depletion | Q36465901 | ||
| Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines | Q36698590 | ||
| Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents | Q36761728 | ||
| Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct | Q36799639 | ||
| Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems | Q38022615 | ||
| Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. | Q38339920 | ||
| Pathways of human cell post-replication repair | Q38596913 | ||
| The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes | Q39681341 | ||
| DNA damage tolerance, mismatch repair and genome instability | Q40582064 | ||
| Cellular accumulation of the anticancer agent cisplatin: a review | Q40917698 | ||
| Nucleotide excision repair and the link with transcription | Q40930028 | ||
| Evidence that mammalian cells possess homologous recombinational repair pathways | Q40936355 | ||
| DNA repair capacity and cisplatin sensitivity of human testis tumour cells | Q41121314 | ||
| DNA repair: enzymatic mechanisms and relevance to drug response | Q41127626 | ||
| Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity | Q41142678 | ||
| Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel | Q41144344 | ||
| DNA loop repair by human cell extracts | Q41429743 | ||
| DNA excision repair pathways | Q41441658 | ||
| Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines | Q41488009 | ||
| Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy | Q41499982 | ||
| Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines | Q41514546 | ||
| Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines | Q41584816 | ||
| Nucleotide excision repair in mammalian cells | Q41593250 | ||
| Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells | Q41673804 | ||
| Reversal of Cisplatin Resistance with Amphotericin B in a Non-small Cell Lung Cancer Cell Line | Q41682986 | ||
| Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? | Q41688654 | ||
| Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro | Q41692695 | ||
| Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene | Q41744077 | ||
| Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells | Q41750642 | ||
| The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cells | Q41977078 | ||
| Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu | Q42807740 | ||
| Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells | Q43632149 | ||
| Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo | Q44073877 | ||
| The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques | Q44317496 | ||
| Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin | Q48109736 | ||
| UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. | Q50537563 | ||
| The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents. | Q51607367 | ||
| Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. | Q51608557 | ||
| The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. | Q52528138 | ||
| Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). | Q52832659 | ||
| An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines. | Q54313648 | ||
| Overexpression of metallothionein confers resistance to anticancer drugs. | Q54376480 | ||
| Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. | Q54447087 | ||
| Structural aspects of platinum anticancer drug interactions with DNA | Q60174164 | ||
| Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells | Q64382166 | ||
| Mechanisms of resistance to cisplatin | Q67649969 | ||
| Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes | Q68985882 | ||
| P433 | issue | 4 | |
| P921 | main subject | platinum | Q880 |
| P304 | page(s) | 243-254 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Drug Resistance Updates | Q3040081 |
| P1476 | title | Recent insights into platinum drug resistance in cancer | |
| P478 | volume | 1 |
| Q41791297 | A standardized extract of Ginkgo biloba neutralizes cisplatin-mediated reproductive toxicity in rats. |
| Q46382410 | DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects. |
| Q34725611 | DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. |
| Q33523365 | Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2). |
| Q36616527 | Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells |
| Q39229225 | Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator. |
| Q37352731 | In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer |
| Q72989495 | Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines |
| Q95811927 | Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy |
| Q34866688 | Molecular aspects of resistance to antitumor platinum drugs. |
| Q39018004 | Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells. |
| Q33180580 | Preclinical perspectives on platinum resistance |
| Q45256975 | Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck |
| Q41560943 | Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. |
| Q40688740 | Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin |
| Q58616091 | Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway |
| Q59172840 | Synthesis and stereochemical characterisation of platinum(II) complexes with the antiviral agents penciclovir and famciclovir |
| Q36384037 | The effects of MOTILIPERM on cisplatin induced testicular toxicity in Sprague-Dawley rats. |
Search more.